April 2020 - Evolution Biotechnologies
0
archive,date,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-16.4,qode-theme-bridge,wpb-js-composer js-comp-ver-5.4.7,vc_responsive

Bedford, UK, April 3rd 2020 Evolution Biotechnologies (www.evolutionbiotech.com), the UK-based company pioneering the use of biological control to benefit human health, today reports that it has received notice of award of Hong Kong patent number 1252537, “Acaricides”. This patent protects the use of replicating biological agents for control of house dust mites, a key cause of asthma and other allergic conditions, and follows on from the award of European patent 3331366. Examination of applications proceeding from the underlying PCT application GB2016/052455 is proceeding in other jurisdictions. Dr. David Harper, Evolution’s CEO, said “this represents a key part of our strategy and highlights the...